Patients with Atrial Fibrillation have a higher risk of forming clots in the heart which can lead to a stroke.
For decades, warfarin has been the drug of choice in preventing blood clots in atrial fibrillation. There are now other types of anticoagulants which are widely used, called direct oral anticoagulants (DOACs), which
We are looking to give patients on warfarin a choice of which type of drug they would like to take.
For more details to help with this choice please read the attached letter
